MOHAMMAD CHOWDHURY: Open Payments
NPI 1639335607 · RAYMORE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 7 payments from 6 companies in 2025. Trend: 2023 $698 · 2024 $436 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| Otsuka America Pharmaceutical, Inc. | 1 | $96 |
| ACADIA Pharmaceuticals Inc | 1 | $34 |
Products named: UZEDY, AUSTEDO XR, CAPLYTA, Auvelity, COBENFY, ABILIFY MAINTENA, NUPLAZID.
Industry payments across MO — which companies pay providers there.
